Saiki Atsuhito, Yamaguchi Takashi, Sasaki Akira, Naitoh Takeshi, Matsubara Hisahiro, Yokote Koutaro, Okazumi Shinichi, Ugi Satoshi, Yamamoto Hiroshi, Ohta Masayuki, Ishigaki Yasushi, Kasama Kazunori, Seki Yosuke, Tsujino Motoyoshi, Shirai Kohji, Miyazaki Yasuhiro, Masaki Takayuki, Nagayama Daiji, Tatsuno Ichiro
Center of Diabetes, Endocrine and Metabolism, Toho University Sakura Medical Center, 564-1, Shimoshizu, Sakura-City, Chiba 285-8741 Japan.
Department of Surgery, Iwate Medical University School of Medicine, Iwate, Japan.
Diabetol Int. 2021 Jan 2;12(3):303-312. doi: 10.1007/s13340-020-00487-x. eCollection 2021 Jul.
The J-SMART study was the first national survey of Japanese patients undergoing laparoscopic sleeve gastrectomy (LSG). We performed a subgroup analysis of J-SMART focusing on the differences in patient background and diabetes remission between patients with BMI 32-34.9 kg/m and those with higher BMI.
In this multi-institutional retrospective study at 10 certified bariatric institutions, 203 Japanese with type 2 diabetes (T2D) and BMI of 32 kg/m or higher were analyzed (mean age: 49.2 years, BMI: 43.8 kg/m, HbA1c: 7.6%). Patients were stratified into five groups according to preoperative BMI.
Background characteristics in BMI 32.0-34.9 group were higher adjusted HbA1c, higher visceral/subcutaneous fat area ratio, higher prevalence of diabetic retinopathy, higher frequency of insulin use and lower serum C-peptide. Although 2-year percent total weight loss (21.7%) and diabetes complete remission (CR) rate (52.4%) were lower in BMI 32.0-34.9 group, diabetes improvement rate was 81.0%, and the decrease in HbA1c and number of antidiabetic drugs were comparable or greater than those with higher BMI. Higher BMI and no insulin use were significant independent predictors of diabetes CR. No significant independent predictor was identified for diabetes improvement.
The patients with 32-34.9 kg/m were characterized by more severe visceral obesity, T2D and the complications, and lower intrinsic insulin secretion capacity. LSG should be considered as a treatment option for patients with BMI 32-34.9 kg/m, to improve diabetes control.
J-SMART研究是日本首例针对接受腹腔镜袖状胃切除术(LSG)患者的全国性调查。我们对J-SMART研究进行了亚组分析,重点关注体重指数(BMI)为32-34.9kg/m²的患者与BMI更高的患者在患者背景和糖尿病缓解方面的差异。
在这项对10家认证减肥机构进行的多机构回顾性研究中,分析了203名2型糖尿病(T2D)且BMI为32kg/m²或更高的日本患者(平均年龄:49.2岁,BMI:43.8kg/m²,糖化血红蛋白:7.6%)。患者根据术前BMI分为五组。
BMI 32.0-34.9组的背景特征为糖化血红蛋白校正值更高、内脏/皮下脂肪面积比更高、糖尿病视网膜病变患病率更高、胰岛素使用频率更高以及血清C肽更低。尽管BMI 32.0-34.9组的2年总体重减轻百分比(21.7%)和糖尿病完全缓解(CR)率(52.4%)较低,但其糖尿病改善率为81.0%,糖化血红蛋白的降低和抗糖尿病药物数量的减少与BMI更高的组相当或更大。更高的BMI和未使用胰岛素是糖尿病CR的显著独立预测因素。未发现糖尿病改善的显著独立预测因素。
BMI为32-34.9kg/m²的患者具有更严重的内脏肥胖、T2D及其并发症,以及更低的内源性胰岛素分泌能力。对于BMI为32-34.9kg/m²的患者,应考虑将LSG作为一种治疗选择,以改善糖尿病控制。